Immunology of Chagas' disease
Abstract
After reviewing present knowledge of the morphology, multiplication, and transmission of Trypanosoma cruzi, this Memorandum discusses the animal models that may be of value in understanding the immune mechanisms operating in Chagas' disease. The role of both circulating antibody and cell-mediated immunity in protection against the parasite is discussed, together with the possibility that immunopathological mechanisms may be responsible for some of the lesions found in patients with Chagas' disease. The immunodiagnostic methods at present available are also reviewed, and the possibility of producing a vaccine for human use is considered in the light of recent findings in experimental animals. A series of recommendations for further research is included.
Similar articles
-
[Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].Acta Physiol Pharmacol Latinoam. 1985;35(1):1-47. Acta Physiol Pharmacol Latinoam. 1985. PMID: 2932884 Spanish.
-
[Immunologic studies on Trypanosoma cruzi, the causative agent of Chagas' disease].Z Tropenmed Parasitol. 1973 Mar;24(1):72-80. Z Tropenmed Parasitol. 1973. PMID: 4200244 German. No abstract available.
-
Acquired cell-mediated immunodepression in acute Chagas' disease.J Clin Invest. 1978 Dec;62(6):1132-41. doi: 10.1172/JCI109232. J Clin Invest. 1978. PMID: 107195 Free PMC article.
-
Macrophages in experimental Chagas' disease.Immunol Ser. 1994;60:495-502. Immunol Ser. 1994. PMID: 8251589 Review.
-
Infection and invasion mechanisms of Trypanosoma cruzi in the congenital transmission of Chagas' disease: a proposal.Biol Res. 2010;43(3):307-16. Epub 2010 Nov 30. Biol Res. 2010. PMID: 21249302 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources